Beneficial Effects of Ibuprofen on Pentylenetetrazol-induced Convulsion

dc.authorid0000-0001-5427-8428
dc.contributor.authorDurankus, Ferit
dc.contributor.authorSenkal, Evrim
dc.contributor.authorSunnetci, Eda
dc.contributor.authorAlbayrak, Yakup
dc.contributor.authorBeyazyuz, Murat
dc.contributor.authorAtasoy, Ozum
dc.contributor.authorErbas, Oytun
dc.date.accessioned2025-05-10T19:47:32Z
dc.date.issued2020
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractIbuprofen is a non-steroidal anti-inflammatory drug (NSAID) that is commonly used as an anti-inflammatory, anti-pyretic, and analgesic. Although some studies have focused on the anti-inflammatory and anti-pyretic properties of ibuprofen during febrile convulsions, only one has investigated its antiepileptic effects. In the present study, we aimed to investigate the effects of ibuprofen in rats exposed to pentylenetetrazol (PTZ)-induced seizures. In total, 48 rats were randomly divided in two groups: Group A for electroencephalography (EEG) recordings and Group B for behavioral assessment. All EEG recordings and behavioral assessment protocols were performed. In addition, groups were compared in terms of prostaglandin F2 alfa (PGF2 alpha) levels in the brain. We demonstrated the beneficial effects of the administration of ibuprofen in PTZ-induced seizures in rats via the following findings: spike percentages and Racine convulsion scale values were significantly lower and first myoclonic jerk (FMJ) onset times were significantly higher in the ibuprofen-administered groups. Moreover, PGF2 alpha levels in the brain were significantly higher in the saline and PTZ 70 mg/kg group than in the control and PTZ 70 mg/kg and 400 mg/kg ibuprofen groups. Our study is the first to demonstrate the beneficial effects of ibuprofen on seizures through behavioral, EEG, and PGF2 alpha brain assessments. Ibuprofen can be used for epilepsy and febrile seizures safely and without inducing seizures. However, further experimental and clinical studies are needed to confirm our results.
dc.identifier.doi10.1007/s11064-020-03101-3
dc.identifier.endpage2416
dc.identifier.issn0364-3190
dc.identifier.issn1573-6903
dc.identifier.issue10
dc.identifier.pmid32719978
dc.identifier.scopus2-s2.0-85088660508
dc.identifier.scopusqualityQ1
dc.identifier.startpage2409
dc.identifier.urihttps://doi.org/10.1007/s11064-020-03101-3
dc.identifier.urihttps://hdl.handle.net/20.500.14730/11413
dc.identifier.volume45
dc.identifier.wosWOS:000553577100001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSpringer/Plenum Publishers
dc.relation.ispartofNeurochemical Research
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectEpilepsy
dc.subjectFebrile
dc.subjectSeizure
dc.subjectIbuprofen
dc.subjectTreatment
dc.titleBeneficial Effects of Ibuprofen on Pentylenetetrazol-induced Convulsion
dc.typeArticle

Dosyalar